New study shows bivalent COVID-19 booster increases antibody response in lung cancer patients Post author: Post published:November 23, 2023 Post category:uncategorized Bivalent booster dose enhanced neutralization of Omicron XBB (sub)variants in non-small cell lung cancer (NSCLC) patients. You Might Also Like Atrial dysfunction assessment tool may help identify stroke risk in people with ATTR-CM November 3, 2025 Rising colorectal cancer rates in young Swiss adults spark concern April 21, 2026 Jumbo phages’ protective shield offers clues for fighting antibiotic resistance February 6, 2025
Atrial dysfunction assessment tool may help identify stroke risk in people with ATTR-CM November 3, 2025